Researchers at the Mount Sinai Covid Informatics Center in New York found that blood thinners can improve the survival chances of Covid-19 patients.
They reported in the Journal of the American College of Cardiology on May 6 that treatment of Covid-19 patients hospitalized with anticoagulants (that is, blood thinners can slow blood clotting) can improve their chances of survival.
The work of the Sinai researchers outlined potentially important treatment avenues for Covid-19 patients.
The study found that in-patient Covid-19 patients receiving anticoagulant therapy had improved outcomes both inside and outside the intensive care unit setting.
However, the researchers cautioned that, given the potential bleeding risk, each case should be evaluated separately.